GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

PeptiDream 4587.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

1,083

+4.23%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2025

Revenue

¥18.52bn

FY2016FY2025

Net income

−¥3.75bn

FY2016FY2025

Free cash flow

−¥14.92bn

FY2016FY2025

Shareholders' equity

¥51.53bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue¥18.52bn¥46.68bn¥28.71bn¥26.85bn¥9.42bn¥11.68bn¥2.07bn¥7.22bn¥6.43bn¥4.90bn
Gross profit¥7.52bn¥34.16bn¥16.86bn¥17.81bn¥6.96bn¥9.46bn¥661.1m¥5.57bn¥4.65bn¥3.53bn
Research and development¥5.02bn¥4.00bn¥3.16bn¥2.92bn¥1.65bn¥1.46bn¥1.79bn¥1.14bn¥921.3m¥362.7m
Operating income−¥5.05bn¥21.39bn¥7.18bn¥9.35bn¥4.05bn¥6.99bn−¥1.77bn¥3.58bn¥2.98bn¥2.49bn
Net income−¥3.75bn¥15.01bn¥3.04bn¥7.55bn¥2.57bn¥4.45bn−¥976.9m¥2.77bn¥2.34bn¥1.89bn
Diluted earnings per share-29.04115.8523.4258.1419.8234.26-64.1522.5119.4714.60

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets¥77.03bn¥93.62bn¥69.46bn¥64.94bn¥26.62bn¥26.27bn¥17.82bn¥20.04bn¥16.51bn¥13.63bn
Cash and short-term investments¥28.68bn¥48.12bn¥19.51bn¥5.25bn¥11.75bn¥7.15bn¥6.99bn¥6.85bn¥3.51bn¥6.56bn
Total liabilities¥25.50bn¥36.85bn¥29.11bn¥32.90bn¥1.62bn¥5.05bn¥839.0m¥2.59bn¥1.80bn¥1.45bn
Debt¥17.04bn¥20.03bn¥22.80bn¥21.40bn¥244.1m—————
Shareholders' equity¥51.53bn¥56.76bn¥40.35bn¥32.04bn¥25.00bn¥21.22bn¥16.98bn¥17.45bn¥14.71bn¥12.18bn
Shares outstanding129m130m130m130m130m130m15m123m120m130m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−¥13.28bn¥23.84bn¥12.38bn−¥295.7m¥6.65bn¥1.73bn¥242.0m¥4.48bn¥1.02bn¥1.53bn
Capital spending−¥1.64bn−¥2.08bn−¥1.21bn−¥3.72bn−¥1.19bn−¥575.9m−¥138.3m−¥195.0m−¥2.44bn−¥1.90bn
Free cash flow−¥14.92bn¥21.77bn¥11.17bn−¥4.02bn¥5.47bn¥1.16bn¥103.7m¥4.29bn−¥1.41bn−¥365.8m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥4.46bn¥4.76bn¥5.66bn¥4.31bn¥4.31bn¥4.23bn¥5.07bn¥5.47bn
Gross profit¥1.94bn¥2.03bn¥2.69bn¥1.67bn¥1.70bn¥1.47bn¥1.96bn¥2.58bn
Operating income−¥1.38bn−¥1.13bn−¥924.8m−¥1.43bn−¥1.26bn−¥1.36bn−¥3.17bn−¥123.1m
Net income−¥1.14bn−¥854.9m−¥531.9m−¥1.09bn−¥1.09bn−¥1.03bn−¥2.61bn−¥304.7m
Diluted earnings per share-8.90-6.65-4.12-8.48-8.44-8.00-20.10-2.35
Cash from operations−¥874.0m−¥1.04bn−¥732.0m−¥1.59bn−¥1.13bn−¥9.82bn¥1.0m¥26.50bn
Capital spending−¥242.0m−¥273.0m−¥257.0m−¥472.0m−¥229.0m−¥682.0m−¥658.0m−¥489.0m
Free cash flow−¥1.12bn−¥1.32bn−¥989.0m−¥2.06bn−¥1.36bn−¥10.51bn−¥657.0m¥26.01bn
Total assets¥72.23bn¥74.70bn¥77.03bn¥77.57bn¥78.54bn¥80.73bn¥93.62bn¥93.43bn
Cash and short-term investments¥23.60bn¥25.55bn¥28.68bn¥30.53bn¥33.33bn¥35.48bn¥48.12bn¥50.42bn
Debt¥15.69bn¥2.61bn¥17.04bn¥2.87bn¥18.61bn¥2.59bn¥2.59bn¥2.59bn
Shareholders' equity¥48.56bn¥49.75bn¥51.53bn¥52.60bn¥53.67bn¥54.79bn¥56.76bn¥58.47bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-11.6%9.7%15.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin63.9%63.2%65.4%66.2%
Operating margin25.1%27.2%30.9%32.2%
Net margin17.3%18.1%20.4%21.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-57.022.863.535.7128.4152.9-87.3192.8198.3208.3
Price to sales11.67.36.710.135.158.341.174.072.080.4

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 2-for-1 split · 28 Jun 2017
  • 4-for-1 split · 26 Jun 2015

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.